Week In Review: Blackstone Buys A $100 Million Stake In China Medical Device Company

Blackstone will buy a stake rumored to be about $100 million in Suzhou Xinrong Best Medical Instrument Co., a maker of orthopedic implants; China's Livzon Mabpharm will collaborate with Epirus Biopharma of Boston to develop up to five biosimilar drugs for the China market; iHealth, a Tianjin company that makes smartphone-compatible health monitoring device devices, received a $25 million capital investment from Xiaomi Ventures; Sagent Pharma announced the second US launch of a product from its partnership with Hengrui Medicine; and Biocept, a San Diego device maker, plans to expand to China after being awarded a China patent for its blood-borne oncology diagnostic tests.

Help employers find you! Check out all the jobs and post your resume.